Revenue
2023
2024
2025
Longevity Health Holdings, Inc. (XAGE)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.9M | $50,318 | $0 | — | — |
| Gross profit | $1.1M | $43,961 | $0 | — | — |
| Research & development | $788,888 | $1.1M | $2.5M | $2.2M | — |
| Operating expenses | $8.2M | $5.0M | $5.9M | $5.5M | — |
| Operating income | −$7.1M | −$5.0M | −$5.9M | −$5.5M | −$467,431 |
| EBITDAderived | −$7.0M | −$4.9M | −$5.8M | −$5.4M | — |
| Net income | −$6.9M | −$10.4M | −$15.4M | −$9.1M | −$329,382 |
| Basic EPSper diluted share | -$4.83 | -$14.56 | -$1.46 | -$5.47 | — |
| Diluted EPSper diluted share | -$4.83 | -$14.56 | -$1.46 | -$5.47 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 16, 2026Form 4 | Ajjarapu J. RamChief Executive Officer | BuyCommon Stock · indirect | 689.7K | $0.29 | $200.0K | 689.7K |
| Sep 13, 2024Form 4 | Upton Richard ADirector | BuyCommon Stock | 5.0K | $0.47 | $2.4K | 15.0K |
| Sep 10, 2024Form 4 | Cassaday Bryan J.Chief Financial Officer | BuyCommon Stock | 475 | $0.46 | $218.50 | 4.3K |
| Sep 6, 2024Form 4 | Spenlehauer GillesDirector | BuyCommon Stock · indirect | 1.0K | $0.51 | $514.59 | 7.6K |
| Sep 6, 2024Form 4 | Gregory KathrynDirector | BuyCommon Stock · indirect | 1.3K | $0.51 | $642.60 | 22.5K |